About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalChina
Clinical Trials (16)
View allTotal Trials
16
As Lead Sponsor
9
As Collaborator
7
Total Enrollment
2,901
By Phase
PHASE3: 3PHASE1: 10PHASE1/PHASE2: 3
By Status
UNKNOWN: 6ACTIVE_NOT_RECRUITING: 3COMPLETED: 3NOT_YET_RECRUITING: 2RECRUITING: 2
Clinical Trials Pipeline16 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07109531Lead Sponsor
ASKC202 Combined With Limertinib Versus Platinum-based Chemotherapy in Treatment of Locally Advanced or Metastatic NSCLC With MET Amplification/Overexpression After Failure of EGFR-TKI Therapy
PHASE3Not yet recruiting
286 participants
Started: Aug 31, 2025 · Completed: Dec 31, 2028
NCT06614608Lead Sponsor
The Safety and Pharmacokinetics of ASKC200 in Osteoarthritic Knee Pain
PHASE1Not yet recruiting
24 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2025
NCT06206733Collaborator
ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ Adenocarcinoma
PHASE3Recruiting
780 participants
Started: Jan 25, 2024 · Completed: Dec 30, 2028
NCT05509985Collaborator
A Phase 1 Study of ASKG315 in Patients With Advanced Solid Tumors
PHASE1Unknown
100 participants
Started: Aug 9, 2023 · Completed: Sep 9, 2024
NCT05867420Collaborator
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
PHASE1Recruiting
104 participants
Started: Aug 3, 2023 · Completed: Dec 31, 2025
Locations (1)
Headquarters
Nanjing, China
Map
Loading map...